211 related articles for article (PubMed ID: 16392827)
1. Substituted 2-thioxoimidazolidin-4-ones and imidazolidine-2,4-diones as fatty acid amide hydrolase inhibitors templates.
Muccioli GG; Fazio N; Scriba GK; Poppitz W; Cannata F; Poupaert JH; Wouters J; Lambert DM
J Med Chem; 2006 Jan; 49(1):417-25. PubMed ID: 16392827
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and activity of 1,3,5-triphenylimidazolidine-2,4-diones and 1,3,5-triphenyl-2-thioxoimidazolidin-4-ones: characterization of new CB1 cannabinoid receptor inverse agonists/antagonists.
Muccioli GG; Wouters J; Charlier C; Scriba GK; Pizza T; Di Pace P; De Martino P; Poppitz W; Poupaert JH; Lambert DM
J Med Chem; 2006 Feb; 49(3):872-82. PubMed ID: 16451053
[TBL] [Abstract][Full Text] [Related]
3. Substituted 5,5'-diphenyl-2-thioxoimidazolidin-4-one as CB1 cannabinoid receptor ligands: synthesis and pharmacological evaluation.
Muccioli GG; Martin D; Scriba GK; Poppitz W; Poupaert JH; Wouters J; Lambert DM
J Med Chem; 2005 Apr; 48(7):2509-17. PubMed ID: 15801840
[TBL] [Abstract][Full Text] [Related]
4. Binding mode of new (thio)hydantoin inhibitors of fatty acid amide hydrolase: comparison with two original compounds, OL-92 and JP104.
Michaux C; Muccioli GG; Lambert DM; Wouters J
Bioorg Med Chem Lett; 2006 Sep; 16(18):4772-6. PubMed ID: 16844375
[TBL] [Abstract][Full Text] [Related]
5. Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase.
Minkkilä A; Saario SM; Käsnänen H; Leppänen J; Poso A; Nevalainen T
J Med Chem; 2008 Nov; 51(22):7057-60. PubMed ID: 18983140
[TBL] [Abstract][Full Text] [Related]
6. Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
Vincent F; Nguyen MT; Emerling DE; Kelly MG; Duncton MA
Bioorg Med Chem Lett; 2009 Dec; 19(23):6793-6. PubMed ID: 19850474
[TBL] [Abstract][Full Text] [Related]
7. 1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase.
Forster L; Ludwig J; Kaptur M; Bovens S; Elfringhoff AS; Holtfrerich A; Lehr M
Bioorg Med Chem; 2010 Jan; 18(2):945-52. PubMed ID: 20005725
[TBL] [Abstract][Full Text] [Related]
8. 3-Heterocycle-phenyl N-alkylcarbamates as FAAH inhibitors: design, synthesis and 3D-QSAR studies.
Käsnänen H; Myllymäki MJ; Minkkilä A; Kataja AO; Saario SM; Nevalainen T; Koskinen AM; Poso A
ChemMedChem; 2010 Feb; 5(2):213-31. PubMed ID: 20024981
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure-activity relationship of some new anti-arrhythmic 5-arylidene imidazolidine-2,4-dione derivatives.
Pekala E; Stadnicka K; Broda A; Zygmunt M; Filipek B; Kieć-Kononowicz K
Eur J Med Chem; 2005 Mar; 40(3):259-69. PubMed ID: 15725495
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors.
Myllymäki MJ; Saario SM; Kataja AO; Castillo-Melendez JA; Nevalainen T; Juvonen RO; Järvinen T; Koskinen AM
J Med Chem; 2007 Aug; 50(17):4236-42. PubMed ID: 17665899
[TBL] [Abstract][Full Text] [Related]
11. Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.
Seierstad M; Breitenbucher JG
J Med Chem; 2008 Dec; 51(23):7327-43. PubMed ID: 18983142
[No Abstract] [Full Text] [Related]
12. Fatty acid amide hydrolase inhibitors. Surprising selectivity of chiral azetidine ureas.
Hart T; Macias AT; Benwell K; Brooks T; D'Alessandro J; Dokurno P; Francis G; Gibbons B; Haymes T; Kennett G; Lightowler S; Mansell H; Matassova N; Misra A; Padfield A; Parsons R; Pratt R; Robertson A; Walls S; Wong M; Roughley S
Bioorg Med Chem Lett; 2009 Aug; 19(15):4241-4. PubMed ID: 19515560
[TBL] [Abstract][Full Text] [Related]
13. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
Russo R; Loverme J; La Rana G; Compton TR; Parrott J; Duranti A; Tontini A; Mor M; Tarzia G; Calignano A; Piomelli D
J Pharmacol Exp Ther; 2007 Jul; 322(1):236-42. PubMed ID: 17412883
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, molecular modelling and enzymatic evaluation of (+/-)3,5-diphenyl-2-thioxoimidazolidin-4-ones as new potential cyclooxygenase inhibitors.
Gauthier MP; Michaux C; Rolin S; Vastersaegher C; de Leval X; Julémont F; Pochet L; Masereel B
Bioorg Med Chem; 2006 Feb; 14(4):918-27. PubMed ID: 16214349
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and schistosomicidal activity of new substituted thioxo-imidazolidine compounds.
Albuquerque MC; Silva TG; Pitta MG; Silva AC; Silva PG; Malagueño E; Santana JV; Wanderley AG; Lima MC; Galdino SL; Barbe J; Pitta IR
Pharmazie; 2005 Jan; 60(1):13-7. PubMed ID: 15700773
[TBL] [Abstract][Full Text] [Related]
16. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.
Mor M; Rivara S; Lodola A; Plazzi PV; Tarzia G; Duranti A; Tontini A; Piersanti G; Kathuria S; Piomelli D
J Med Chem; 2004 Oct; 47(21):4998-5008. PubMed ID: 15456244
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of imidazolidine-2,4-dione and 2-thioxoimidazolidin-4-one derivatives as inhibitors of virulence factors production in Pseudomonas aeruginosa.
Mohamed B; Abdel-Samii ZK; Abdel-Aal EH; Abbas HA; Shaldam MA; Ghanim AM
Arch Pharm (Weinheim); 2020 May; 353(5):e1900352. PubMed ID: 32134150
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationships of FAAH inhibitors: cyclohexylcarbamic acid biphenyl esters with chemical modulation at the proximal phenyl ring.
Tarzia G; Duranti A; Gatti G; Piersanti G; Tontini A; Rivara S; Lodola A; Plazzi PV; Mor M; Kathuria S; Piomelli D
ChemMedChem; 2006 Jan; 1(1):130-9. PubMed ID: 16892344
[TBL] [Abstract][Full Text] [Related]
19. The synthesis and biological evaluation of para-substituted phenolic N-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors.
Minkkilä A; Myllymäki MJ; Saario SM; Castillo-Melendez JA; Koskinen AM; Fowler CJ; Leppänen J; Nevalainen T
Eur J Med Chem; 2009 Jul; 44(7):2994-3008. PubMed ID: 19232787
[TBL] [Abstract][Full Text] [Related]
20. Structure based design of novel irreversible FAAH inhibitors.
Wang JL; Bowen SJ; Schweitzer BA; Madsen HM; McDonald J; Pelc MJ; Tenbrink RE; Beidler D; Thorarensen A
Bioorg Med Chem Lett; 2009 Oct; 19(20):5970-4. PubMed ID: 19765986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
